29 August 2019 - Prescription drug pricing appears poised to be an important issue in the 2020 presidential election. 

Identified as Americans’ top health care priority for the new Congress in 2019, the rising cost of prescription drugs has occupied an increasingly prominent place in national discourse. Perhaps, most revealing of the issue’s salience in the approaching presidential race is that every Democratic presidential hopeful from the Senate has sponsored legislation centred on lowering prescription drug costs, and the remaining candidates have pushed their own proposals on the campaign trail.

These candidates’ policies are united by a common aim—lowering prescription drug prices and out-of-pocket costs—but they differ widely in the strategies they adopt to achieve that outcome.

Read Health Affairs article